HealthLynked Corp. (HLYK) financial statements (2022 and earlier)
Company profile
| Business Address |
1726 MEDICAL BLVD NAPLES, FL 34110 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| SIC | 8011 - Offices and Clinics of Doctors of Medicine (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 162 | 110 | 136 | 50 | ||
| Cash and cash equivalents | 162 | 110 | 136 | 50 | ||
| Receivables | 87 | 83 | 115 | 113 | ||
| Inventory, net of allowances, customer advances and progress billings | 95 | 70 | ||||
| Inventory | 95 | 70 | ||||
| Prepaid expense | 119 | 29 | 82 | |||
| Deferred costs | 19 | 96 | 122 | |||
| Other undisclosed current assets | 59 | |||||
| Total current assets: | 404 | 403 | 375 | 367 | ||
| Noncurrent Assets | ||||||
| Property, plant and equipment | 437 | 514 | 43 | 63 | ||
| Intangible assets, net (including goodwill) | 6,750 | 1,337 | ||||
| Goodwill | 1,148 | 72 | ||||
| Intangible assets, net (excluding goodwill) | 5,602 | 1,265 | ||||
| Deposits noncurrent assets | 10 | 10 | ||||
| Other undisclosed noncurrent assets | 436 | 293 | ||||
| Total noncurrent assets: | 7,623 | 2,144 | 52 | 73 | ||
| TOTAL ASSETS: | 8,027 | 2,547 | 427 | 440 | ||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities, including: | 1,892 | 836 | 394 | 254 | ||
| Other undisclosed accounts payable and accrued liabilities | 1,892 | 836 | 394 | 254 | ||
| Deferred revenue | 89 | ✕ | ✕ | |||
| Debt | 723 | 1,744 | 1,062 | 900 | ||
| Derivative instruments and hedges, liabilities | 89 | 991 | 800 | 398 | ||
| Due to related parties | 301 | 493 | 430 | 917 | ||
| Business combination, contingent consideration, liability | 702 | 500 | ||||
| Other undisclosed current liabilities | 1,086 | 744 | 672 | |||
| Total current liabilities: | 4,882 | 5,309 | 3,359 | 2,470 | ||
| Noncurrent Liabilities | ||||||
| Long-term debt and lease obligation | 996 | 81 | 3 | 21 | ||
| Long-term debt, excluding current maturities | 723 | |||||
| Capital lease obligations | ✕ | ✕ | 3 | 21 | ||
| Operating lease, liability | 274 | 81 | ✕ | ✕ | ||
| Other undisclosed noncurrent liabilities | 525 | |||||
| Total noncurrent liabilities: | 1,795 | 81 | 3 | 21 | ||
| Total liabilities: | 6,677 | 5,389 | 3,362 | 2,491 | ||
| Stockholders' equity | ||||||
| Stockholders' equity attributable to parent, including: | 1,350 | (2,843) | (2,935) | (2,051) | ||
| Preferred stock | 3 | |||||
| Common stock | 19 | 11 | 9 | 7 | ||
| Additional paid in capital | 22,851 | 13,016 | 7,532 | 2,638 | ||
| Accumulated deficit | (21,785) | (16,030) | (10,501) | (4,705) | ||
| Other undisclosed stockholders' equity attributable to parent | 262 | 160 | 26 | 8 | ||
| Total stockholders' equity: | 1,350 | (2,843) | (2,935) | (2,051) | ||
| TOTAL LIABILITIES AND EQUITY: | 8,027 | 2,547 | 427 | 440 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|
| Financial services revenue | ✕ | ✕ | ✕ | 4 | |
| Gross profit: | 6,133 | 4,019 | 2,259 | 4 | |
| Operating expenses | (9,205) | (7,228) | (5,231) | (3,895) | |
| Other undisclosed operating income | 2,100 | ||||
| Operating loss: | (3,072) | (3,209) | (2,972) | (1,791) | |
| Nonoperating expense | (2,683) | (2,320) | (2,819) | (790) | |
| Investment income, nonoperating | 209 | (589) | (870) | (330) | |
| Interest and debt expense | (382) | (122) | (141) | (291) | |
| Loss from continuing operations before equity method investments, income taxes: | (6,137) | (5,650) | (5,932) | (2,872) | |
| Other undisclosed income from continuing operations before income taxes | 382 | 122 | 141 | 291 | |
| Net loss attributable to parent: | (5,755) | (5,529) | (5,791) | (2,581) | |
| Preferred stock dividends and other adjustments | (446) | ||||
| Net loss available to common stockholders, diluted: | (6,201) | (5,529) | (5,791) | (2,581) | |
Comprehensive Income ($ in thousands)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|
| Net loss: | (5,755) | (5,529) | (5,791) | (2,581) | |
| Comprehensive loss, net of tax, attributable to parent: | (5,755) | (5,529) | (5,791) | (2,581) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.